Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-003157

Director sold 3,000 shares at $285.16 ($855,480)

  • Director acquired 3,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

DWEK RAYMOND · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-14 Exercise or conversion : show line 1 in the form 10b5-1 +3,000 $175.43 $526,290 4,750 D
2025-04-14 Sale : show line 2 in the form 10b5-1 −3,000 $285.16 $855,480 1,750 D
Open-market sales · 3,000 sh · avg $285.16 · $855,480

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-04-14 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −3,000 $175.43 2025-06-26 3,000 3,000 D
Loading xslF345X05/primarydocument.xml…